Vitreomacular Interface Disorders in Behçet’s Uveitis

نویسندگان

  • Hilal Eser Öztürk
  • Özlem Eşki Yücel
  • Yüksel Süllü
چکیده

Objectives To determine the prevalence of vitreomacular interface (VMI) disorders in patients with Behçet's uveitis and assess the relationship between VMI disorders and clinical characteristics. Materials and Methods The macular optical coherence tomography (OCT) images of 160 eyes of 96 patients with Behçet's uveitis who were being followed in the Uvea-Behçet's clinic were assessed retrospectively for VMI disorders including posterior vitreous detachment (PVD), epiretinal membrane (ERM), vitreomacular adhesion (VMA), vitreomacular traction (VMT), full-thickness macular hole (FTMH), lamellar hole (LH) and pseudohole. Results Twenty-four patients (25%) with unilateral and 72 patients with bilateral uveitis were included in the study. Six (30%) of 20 eyes with anterior uveitis and 57 (40.7%) of 140 eyes with posterior uveitis, in total 63 (39.4%) eyes of 160 eyes had at least one VMI disorder. PVD was detected in 4 eyes (2.5%), ERM in 48 eyes (30%), VMA in 12 eyes (7.5%), and LH in 1 eye (0.6%). None of the eyes had VMT, FTMH, or pseudohole. ERM was detected in 13 eyes (8.1%) on fundus examination and 48 (30%) eyes by OCT (p=0.001). VMI was detected in 12 (50%) of 24 eyes with prior intraocular surgery and 51 (37.5%) of 136 eyes without. The mean duration of uveitis was 7.3±5.8 years in patients with VMI disorders and 5.8±7.7 years in patients without (p=0.04). There was no relation between VMI disorders and anatomic location of uveitis, history of past ocular surgery, number of ocular/periocular steroid injections, or visual acuity. Conclusion VMI disorders are common in patients with Behçet's uveitis. Their frequency increases with the duration of uveitis. OCT is more sensitive than fundus examination in the detection of VMI disorders.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Ciliary body metastasis masquerading as scleritis.

of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003;82:60–76. 10 Mousa AR, Marafie AA, Rifai KM, et al. Behçet’s disease in Kuwait, Arabia. A report of 29 cases and a review. Scand J Rheumatol 1986;15:310–32. 11 Atmaca LS. Fundus changes associated with Behçet’s disease. Graefes Arch Clin Exp Ophthalmol 1989;227:340–4. 12 Tugal...

متن کامل

Incomplete Vitreomacular Traction Release Using Intravitreal Ocriplasmin

PURPOSE To report the clinical course of our first 7 consecutive patients treated with intravitreal ocriplasmin (Jetrea(®)). METHODS Retrospective case series of the first 7 patients treated with ocriplasmin between January and December 2013 at an academic tertiary care center. RESULTS The average age was 78.4 years (range: 63-92). Five patients were pseudophakic and 2 patients were phakic ...

متن کامل

Insights into Behçet’s disease

Behçet’s disease is a chronic relapsing multi-organ inflammatory disorder characterized as a triad of oral and genital ulcers, uveitis. Characteristic manifestations of Behçet’s disease are joints, skin, central nervous system and gastrointestinal tract involvement. Behçet’s disease has a complicated genetic etiology. However, epidemiological studies recommend that genetic factors have a signif...

متن کامل

SCIENTIFIC CORRESPONDENCE The incidence and pathology of conjunctival ulceration in Behçet’s syndrome

Aims: To describe the results of a study of the incidence of conjunctival ulceration and its pathology as a manifestation of Behçet’s syndrome. Methods: The authors reviewed retrospectively medical charts of 152 patients with Behçet’s syndrome seen at the uveitis service of Okayama University Hospital from January 1995 to December 1999. Criteria used to diagnose Behçet’s syndrome in this study ...

متن کامل

CLINICAL SCIENCE Human recombinant interferon alfa-2a for the treatment of Behçet’s disease with sight threatening posterior or panuveitis

Background: Behçet’s disease is a multisystem vasculitis of unknown origin. Standard treatment mainly comprises systemic immunosuppressive agents. Ocular involvement, mostly posterior uveitis with retinal vasculitis, leads to blindness in 20–50% of the involved eyes within 5 years. The efficacy of interferon alfa-2a was studied in patients with sight threatening posterior uveitis or retinal vas...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 47  شماره 

صفحات  -

تاریخ انتشار 2017